ESPU Congress 2018 - Programme Book

34 29 th CONGRESS OF THE ESPU 08:52–09:34 S5: VESICOURETERAL REFLUX 2 Moderators: Goedele Beckers (Netherlands), Alexander Springer (Austria) 08:52–08:55 S5-1 (PP) ★ POSTNATAL IMAGING OF PRENATALLY DETECTED HYRONEPHROSIS–WHEN IS VOIDING CYSTOURETHROGRAM NECESSARY? Sofia VISURI  1 , Reetta KIVISAARI  2 , Timo JAHNUKAINEN  3 and Seppo TASKINEN  1 1 Helsinki University Hospital, Department of Pediatric surgery, Helsinki, FINLAND 2 Helsinki University Hospital, Department of Pediatric Radiology, Helsinki, FINLAND 3 Helsinki University Hospital, Department of Pediatric Nephrology and Transplantation, Helsinki, FINLAND 08:55–08:58 S5-2 (PP) DIAGNOSTIC ACCURACY OF VOIDING DYSFUNCTION PATTERNS AS A PREDICTIVE TOOL OF VESICOURETERAL REFLUX RESOLUTION AFTER FIRST ENDOSCOPIC TREATMENT José A MARCH, Agustín SERRANO-DURBÁ, Alba POLO, Povo IVAN, Mari Angeles CONCA and Carlos DOMÍNGUEZ La Fe Universitarian Hospital, Pediatric Urology Unit,Valencia, SPAIN 08:58–09:01 S5-3 (PP) FOOT PRINT SIGN: COULD VOIDING CYSTOURETHROGRAPHY DISCOVER POOR RENAL FUNCTION IN VESICOURETERAL REFLUX? Mehrnoosh SAMAEI  1 , Sahar EFTEKHARZADEH  1 , Ehsan SADEGHIAN  1 , Mehrzad MEHDIZADEH  1 and Abdol-Mohammad KAJBAFZADEH  2 1 Children’s Hospital Medical Center, Tehran University of Medical Sciences, Pediatric Urology Research Center, Tehran, (ISLAMIC REPUBLIC OF IRAN) 2 Children’s Hospital, Urology, Tehran, (ISLAMIC REPUBLIC OF IRAN) 09:01–09:04 S5-4 (PP) ★ DID OUR CURRENT INITIAL TREATMENT PRACTICE CHANGE AFTER EAU/ESPU VESICOURETERAL REFLUX RISK GROUPING? Eda TOKAT  1 , Serhat GUROCAK  1 , Iyimser URE  2 , Cenk ACAR  3 , Zafer SINIK  4 and Ozgur TAN  1 1 Gazi University School of Medicine, Department of Urology, Section of Paediatric Urology, Ankara, TURKEY 2 Eskisehir Osmangazi University School of Medicine, Department of Urology, Eskisehir, TURKEY 3 Eryaman Hospital, Department of Urology, Ankara, TURKEY 4 Odak Hospital, Department of Urology, Denizli, TURKEY 09:01–09:04 S5-5 (PP) [PRESENTATION GROUPED WITH PREVIOUS] HOW DID OUR TREATMENTS BEFORE AND AFTER EAU/ESPU VUR RISK GROUPING SYSTEM AFFECT OUR EARLY SUCCESS RATES? Eda TOKAT  1 , Serhat GUROCAK  1 , Iyimser URE  2 , Cenk ACAR  3 , Zafer SINIK  4 and Ozgur TAN  1 1 Gazi University School of Medicine, Department of Urology, Section of Paediatric Urology, Ankara, TURKEY 2 Eskisehir Osmangazi University School Of Medicine, Department of Urology, Eskisehir, TURKEY 3 Eryaman Hospital, Department of Urology, Ankara, TURKEY 4 Odak Hospital, Department of Urology, Denizli, TURKEY